Epigenomic mapping reveals distinct B cell acute lymphoblastic leukemia chromatin architectures and regulatorsKelly R. Barnett(St. Jude Children's Research Hospital), Daniel Savic(St. Jude Children's Research Hospital)Cell GenomicsNovember 20, 202310.1016/j.xgen.2023.100442Cited by 14SaveCiteExport RISWatch citationsRelated PapersEpigenetic activation of the FLT3 gene by ZNF384 fusion confers a therapeutic susceptibility in acute lymphoblastic leukemia|Nature Communications|2022|27Differentiation-dependent EBF1 activity determines <i>CD22</i> transcription and leukemia sensitivity to inotuzumab ozogamicin|Blood|2025|5Functional investigation of inherited noncoding genetic variation impacting the pharmacogenomics of childhood acute lymphoblastic leukemia treatment|medRxiv|2023|0